Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysis.
about
Potential role for metformin in urologic oncologyUnexploited Antineoplastic Effects of Commercially Available Anti-Diabetic DrugsSomething old, something new and something very old: drugs for treating type 2 diabetesCancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysisGeneralized enrichment analysis improves the detection of adverse drug events from the biomedical literatureLatest insights into the risk of cancer in diabetesThiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysisThey see a rat, we seek a cure for diseases: the current status of animal experimentation in medical practiceLack of the effect of lobeglitazone, a peroxisome proliferator-activated receptor-γ agonist, on the pharmacokinetics and pharmacodynamics of warfarin.Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality.Update on Safety Issues Related to Antihyperglycemic TherapyResponse: the risk of bladder cancer in korean diabetic subjects treated with pioglitazone (diabetes metab j 2012;36:371-8).Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic StudyInterpreting adverse signals in diabetes drug development programs.Do we still need pioglitazone for the treatment of type 2 diabetes? A risk-benefit critique in 2013.Risk of bladder cancer among patients with diabetes treated with a 15 mg pioglitazone dose in Korea: a multi-center retrospective cohort study.Management of post-transplant diabetes.Metabolic Surgery for Type 2 Diabetes in Patients with a BMI of <35 kg/m(2): A Surgeon's Perspective.Scientific Evidence and Controversies About Pioglitazone and Bladder Cancer: Which Lessons Can Be Drawn?A review on thiazolidinediones and bladder cancer in human studies.Thiazolidinediones under preclinical and early clinical development for the treatment of Parkinson's disease.Antihyperglycaemic therapies and cancer risk.Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan.Impact of body mass on recurrence and progression in Chinese patients with Ta, T1 urothelial bladder cancer.Letter: the risk of bladder cancer in korean diabetic subjects treated with pioglitazone (diabetes metab j 2012;36:371-8).Pioglitazone inhibits the proliferation and metastasis of human pancreatic cancer cells.Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes.Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer.Pioglitazone and bladder cancer risk: a systematic review and meta-analysis.
P2860
Q26747759-C5E6D656-62C1-4456-8E0C-40B73B5AC4C8Q26750845-C2275B48-6050-4E57-8FEE-E10A261FD622Q26865663-CE25BC90-941F-4430-BBF1-ABCC86A5F0B5Q27002540-BCC8BEB0-679D-40FD-9E29-3469A44C5DC1Q28829259-A480F5C6-F6ED-4504-ADFB-857C4F5E71FCQ33588852-48280BC7-01D4-401B-A4A8-9F5B6D901A86Q34065266-3DFAC8E1-D338-4266-A94F-6EEAAE2A5552Q34384270-1D94A451-E27C-488E-BB40-A2872CB7FD2CQ35161650-35FDC29D-A631-4E0D-87DD-259336FD4AB1Q35817986-D23EDF03-FEEF-474A-A922-BC9E01328B81Q35910429-0335DF77-965B-4178-AADA-597AF76DB47EQ36490156-0DFCE081-C68E-4D22-9251-F69B1258B580Q36712191-98019F92-A1F6-4778-A403-B3183769CC29Q36942266-6CCD6DFA-B834-49BA-95A1-6543A4CECF4DQ37577159-5FACD009-ED2A-4A82-88A5-12255E797ECBQ37583052-1E3CF5F4-0557-4A8B-9E76-849535628BE2Q38063169-018D6C7B-82D6-461B-90FD-C7043A187226Q38096980-84962A19-66AD-410A-8417-AC05152BB17DQ38122640-7D92FFA7-6723-4F50-AFE5-3867D23FADF8Q38193601-A603E316-3857-4D43-A367-38A6AEB83DA3Q38250185-13F1A1EF-F2F5-4DC1-BFB5-6D107CAFD84CQ38250719-69DB6958-B05D-455E-9760-CC202D199AC8Q38417421-FB59DEFB-1C4C-4A2A-AF20-8CB7685B3A1EQ38641190-D9D74A50-140A-4D7E-B336-EF5B2EB9C674Q40649706-12C430AB-5E6D-4DD5-A5F1-85A507F1556BQ40903985-18F0CD03-52A2-490A-ABAA-AB39D4271D6BQ41839186-18BE8D02-6739-4ED8-BE82-8628685C25CBQ42968936-1F409873-7A5A-4DC5-8CCB-742A9BF3028BQ45073276-C8B9E5F1-1428-47F1-9235-02383C464358Q45947012-1ECEE6B8-45B6-4BEB-9596-FCD53128C5FEQ55079635-E97D6821-67F6-4E47-93EB-D5A4B741FC1B
P2860
Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Increased risk of bladder canc ...... ith diabetes: a meta-analysis.
@en
Increased risk of bladder canc ...... ith diabetes: a meta-analysis.
@nl
type
label
Increased risk of bladder canc ...... ith diabetes: a meta-analysis.
@en
Increased risk of bladder canc ...... ith diabetes: a meta-analysis.
@nl
prefLabel
Increased risk of bladder canc ...... ith diabetes: a meta-analysis.
@en
Increased risk of bladder canc ...... ith diabetes: a meta-analysis.
@nl
P2093
P1476
Increased risk of bladder canc ...... ith diabetes: a meta-analysis.
@en
P2093
Shan Zhong
Zhaowei Zhu
Zhoujun Shen
P304
P356
10.1016/J.DIABRES.2012.05.006
P577
2012-06-16T00:00:00Z